CHA actively assists hospital compliance officers, privacy officers and other hospital personnel regarding compliance with the myriad federal and state laws that govern hospital administration and the delivery of health care. CHA also sponsors legislation on behalf of California hospitals on issues related to compliance.
The California Hospital Compliance Manual covers high risk compliance issues including uses of information technology, the False Claims Act, Anti-Kickback laws, physician self-referral, proper cost reporting practices, hospital fair pricing policies, and issues for nonprofit and tax-exempt hospitals. The manual also includes a model compliance plan that hospitals can adapt to fit their operations.
CHA actively assists hospital compliance officers, privacy
officers and other hospital personnel regarding compliance with
the myriad federal and state laws that govern hospital
administration and the delivery of health care. CHA also
sponsors legislation on behalf of California hospitals on issues
related to compliance.
The California Hospital Compliance
Manual covers high risk compliance issues including uses
of information technology, the False Claims Act, Anti-Kickback
laws, physician self-referral, proper cost reporting practices,
hospital fair pricing policies, and issues for nonprofit and
tax-exempt hospitals. The manual also includes a model compliance
plan that hospitals can adapt to fit their operations.
Livanta – the Medicare beneficiary and family-centered care
quality improvement organization (BFCC-QIO) for California – will
be conducting a compliance audit on whether hospitals have
completed their required Memorandum of Agreement (MOA).
December 9 - 10, 2019
Mission Inn Hotel & Spa, Riverside Convention Center
People who live with behavioral health issues can’t always fight for themselves. They frequently feel alone and don’t think they have anyone to turn to. Those who work in behavioral health care make a difference. They are the voices for those who don’t know that help is within reach.
Last month, the Food and Drug Administration (FDA)
cleared a modified Erbe USA Inc. ERBEFLO 24-hour
multi-patient endoscope connector for use. The modified port
connector now includes a backflow prevention feature designed to
help reduce the risk of cross-contamination that was
previously identified in a letter from the FDA in April 2018.
Questions should be directed to the FDA’s Division of Industry
and Consumer Education at DICE@FDA.HHS.GOV, (800) 638-2041 or
The California Department of Public Health has released All
Facilities Letter (AFL) 19-02.1, which rescinds AFL 19-02 and
further clarifies licensing requirements related to treatment for
CHA has released the 10th edition of the Hospital Compliance Manual, written
specifically to help California’s hospital compliance officers,
chief financial officers, legal counsel, and risk managers stay
abreast of pertinent state and federal laws. The manual focuses
on high-risk compliance issues and addresses the key components
of an effective compliance plan.
In preparation for an
upcoming meeting to solicit stakeholder feedback on
possible changes to Title 22 infection control and physical
plant regulations for general acute care hospitals, the
California Department of Public Health has released a series of
questions. More details are available in All
Facilities Letter 18-56.1.
Last week, CHA
shared information about problems some providers have had in
implementing a new state law requiring controlled substance
security prescription forms to include a unique serial number.
This week, the California Board of Pharmacy released updated
frequently asked questions about the law’s requirements and
As of Jan. 1, controlled substance security prescription forms
must include a new, unique serial number in a format approved by
the Department of Justice. However, the new requirement
does not allow for a transition period during which
providers would be allowed to use the previously approved form,
and those who do not have access to the new forms have been
forced to choose between denying care and risking action against
Prescribers are now required to offer naloxone hydrochloride, or
another drug approved by the Food and Drug Administration, to
patients who experience certain conditions related to opioid
depression. The Medical Board of California has
asked questions to assist providers in implementing the new
requirements, which took effect Jan. 1.
Hospitals in need of relief from licensing regulations due to the
recent wildfires across California should refer to All Facilities
Letter 18-51, issued last week by the California Department
of Public Health (CDPH).
Effective Jan. 1, 2020, general acute care hospitals and acute
psychiatric hospitals must adopt and implement a linen laundry
processing policy that aligns with the most recent standards from
the Centers for Disease Control and Prevention and the Centers
for Medicare & Medicaid Services.
As required by Assembly Bill 40 (Chapter 607, Statutes of 2017),
the Department of Justice has developed a method of system
integration through which approved providers may use a qualified
health information system to access the Controlled Substance
Utilization Review and Evaluation System (CURES) database.
As flu season gets underway, providers are encouraged to promote
vaccinations. To assist in this effort, Cal MediConnect has
created free materials in the following languages: Amharic,
Arabic, Armenian, Burmese, Cambodian, Chinese, Dzongkha, English,
Farsi, Hmong, Karen, Kirundi, Korean, Japanese, Nepali, Oromo,
Polish, Russian, Somali, Spanish, Tagalog and Vietnamese.
The Centers for Disease Control and Prevention has updated its
Hepatitis B vaccine information statement to note that a two-dose
series is available. Stocks of the existing edition may be used
up before switching to the updated version. To subscribe to the
CDC’s email notification service about vaccine information
CHA’s Hospital Compliance Manual is the only publication written for hospital compliance officers that integrates California with federal law on high-risk compliance areas. Written by Hooper, Lundy & Bookman, PC, and CHA, the manual focuses on high-risk compliance issues and the key components of an effective compliance program.